単価抗毒素のグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Monovalent Antivenom Market Insights and Forecast to 2027

• レポートコード：QY2112C03889 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は単価抗毒素の世界市場の現状について調査・分析し、2027年までの市場を予測しました。単価抗毒素の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（サンゴヘビ抗毒素、ウミヘビ抗毒素、ブラウンスネーク抗毒素、その他）、用途別市場規模（非営利団体、病院・クリニック）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・単価抗毒素の世界市場概要 ・メーカー別の競争状況、市場シェア ・単価抗毒素の種類別市場規模：サンゴヘビ抗毒素、ウミヘビ抗毒素、ブラウンスネーク抗毒素、その他 ・単価抗毒素の用途別市場規模：非営利団体、病院・クリニック ・北米の単価抗毒素市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの単価抗毒素市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの単価抗毒素市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の単価抗毒素市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの単価抗毒素市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：CSL、Merck、BTG、Pfizer、Haffkine Bio-Pharmaceutical、Vins Bioproducts、Serum Biotech ・単価抗毒素のバリューチェーン・販売チャネル分析 ・単価抗毒素の世界市場動向

Snake antivenom is a medication made up of antibodies used to treat snake bites by venomous snakes. If the hyperimmunizing venom is obtained from a single species, then it is considered a monovalent antivenom.

Market Analysis and Insights: Global Monovalent Antivenom Market
The global Monovalent Antivenom market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Monovalent Antivenom Scope and Segment
Monovalent Antivenom market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Monovalent Antivenom market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Coral Snakes Antivenom
Sea Snakes Antivenom
Brown Snake Antivenom
Others

Segment by Application
Non-profit Institutions
Hospitals and Clinic

By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Serum Biotech

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Monovalent Antivenom Product Introduction
1.2 Market by Type
1.2.1 Global Monovalent Antivenom Market Size Growth Rate by Type
1.2.2 Coral Snakes Antivenom
1.2.3 Sea Snakes Antivenom
1.2.4 Brown Snake Antivenom
1.2.5 Others
1.3 Market by Application
1.3.1 Global Monovalent Antivenom Market Size Growth Rate by Application
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Monovalent Antivenom Sales Estimates and Forecasts 2016-2027
2.2 Global Monovalent Antivenom Revenue Estimates and Forecasts 2016-2027
2.3 Global Monovalent Antivenom Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Monovalent Antivenom Regions by Sales
2.4.1 Global Top Monovalent Antivenom Regions by Sales (2016-2021)
2.4.2 Global Top Monovalent Antivenom Regions by Sales (2022-2027)
2.5 Global Top Monovalent Antivenom Regions by Revenue
2.5.1 Global Top Monovalent Antivenom Regions by Revenue (2016-2021)
2.5.2 Global Top Monovalent Antivenom Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Monovalent Antivenom Sales by Manufacturers
3.1.1 Global Top Monovalent Antivenom Manufacturers by Sales (2016-2021)
3.1.2 Global Top Monovalent Antivenom Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Monovalent Antivenom Sales in 2020
3.2 Global Monovalent Antivenom Revenue by Manufacturers
3.2.1 Global Top Monovalent Antivenom Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Monovalent Antivenom Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Monovalent Antivenom Revenue in 2020
3.3 Global Monovalent Antivenom Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Monovalent Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Monovalent Antivenom Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Monovalent Antivenom Sales by Type
4.1.1 Global Monovalent Antivenom Historical Sales by Type (2016-2021)
4.1.2 Global Monovalent Antivenom Forecasted Sales by Type (2022-2027)
4.1.3 Global Monovalent Antivenom Sales Market Share by Type (2016-2027)
4.2 Global Monovalent Antivenom Revenue by Type
4.2.1 Global Monovalent Antivenom Historical Revenue by Type (2016-2021)
4.2.2 Global Monovalent Antivenom Forecasted Revenue by Type (2022-2027)
4.2.3 Global Monovalent Antivenom Revenue Market Share by Type (2016-2027)
4.3 Global Monovalent Antivenom Price by Type
4.3.1 Global Monovalent Antivenom Price by Type (2016-2021)
4.3.2 Global Monovalent Antivenom Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Monovalent Antivenom Sales by Application
5.1.1 Global Monovalent Antivenom Historical Sales by Application (2016-2021)
5.1.2 Global Monovalent Antivenom Forecasted Sales by Application (2022-2027)
5.1.3 Global Monovalent Antivenom Sales Market Share by Application (2016-2027)
5.2 Global Monovalent Antivenom Revenue by Application
5.2.1 Global Monovalent Antivenom Historical Revenue by Application (2016-2021)
5.2.2 Global Monovalent Antivenom Forecasted Revenue by Application (2022-2027)
5.2.3 Global Monovalent Antivenom Revenue Market Share by Application (2016-2027)
5.3 Global Monovalent Antivenom Price by Application
5.3.1 Global Monovalent Antivenom Price by Application (2016-2021)
5.3.2 Global Monovalent Antivenom Price Forecast by Application (2022-2027)

6 North America
6.1 North America Monovalent Antivenom Market Size by Type
6.1.1 North America Monovalent Antivenom Sales by Type (2016-2027)
6.1.2 North America Monovalent Antivenom Revenue by Type (2016-2027)
6.2 North America Monovalent Antivenom Market Size by Application
6.2.1 North America Monovalent Antivenom Sales by Application (2016-2027)
6.2.2 North America Monovalent Antivenom Revenue by Application (2016-2027)
6.3 North America Monovalent Antivenom Market Size by Country
6.3.1 North America Monovalent Antivenom Sales by Country (2016-2027)
6.3.2 North America Monovalent Antivenom Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Monovalent Antivenom Market Size by Type
7.1.1 Europe Monovalent Antivenom Sales by Type (2016-2027)
7.1.2 Europe Monovalent Antivenom Revenue by Type (2016-2027)
7.2 Europe Monovalent Antivenom Market Size by Application
7.2.1 Europe Monovalent Antivenom Sales by Application (2016-2027)
7.2.2 Europe Monovalent Antivenom Revenue by Application (2016-2027)
7.3 Europe Monovalent Antivenom Market Size by Country
7.3.1 Europe Monovalent Antivenom Sales by Country (2016-2027)
7.3.2 Europe Monovalent Antivenom Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Monovalent Antivenom Market Size by Type
8.1.1 Asia Pacific Monovalent Antivenom Sales by Type (2016-2027)
8.1.2 Asia Pacific Monovalent Antivenom Revenue by Type (2016-2027)
8.2 Asia Pacific Monovalent Antivenom Market Size by Application
8.2.1 Asia Pacific Monovalent Antivenom Sales by Application (2016-2027)
8.2.2 Asia Pacific Monovalent Antivenom Revenue by Application (2016-2027)
8.3 Asia Pacific Monovalent Antivenom Market Size by Region
8.3.1 Asia Pacific Monovalent Antivenom Sales by Region (2016-2027)
8.3.2 Asia Pacific Monovalent Antivenom Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Monovalent Antivenom Market Size by Type
9.1.1 Latin America Monovalent Antivenom Sales by Type (2016-2027)
9.1.2 Latin America Monovalent Antivenom Revenue by Type (2016-2027)
9.2 Latin America Monovalent Antivenom Market Size by Application
9.2.1 Latin America Monovalent Antivenom Sales by Application (2016-2027)
9.2.2 Latin America Monovalent Antivenom Revenue by Application (2016-2027)
9.3 Latin America Monovalent Antivenom Market Size by Country
9.3.1 Latin America Monovalent Antivenom Sales by Country (2016-2027)
9.3.2 Latin America Monovalent Antivenom Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Monovalent Antivenom Market Size by Type
10.1.1 Middle East and Africa Monovalent Antivenom Sales by Type (2016-2027)
10.1.2 Middle East and Africa Monovalent Antivenom Revenue by Type (2016-2027)
10.2 Middle East and Africa Monovalent Antivenom Market Size by Application
10.2.1 Middle East and Africa Monovalent Antivenom Sales by Application (2016-2027)
10.2.2 Middle East and Africa Monovalent Antivenom Revenue by Application (2016-2027)
10.3 Middle East and Africa Monovalent Antivenom Market Size by Country
10.3.1 Middle East and Africa Monovalent Antivenom Sales by Country (2016-2027)
10.3.2 Middle East and Africa Monovalent Antivenom Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Monovalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 CSL Monovalent Antivenom Product Description
11.1.5 CSL Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Monovalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Merck Monovalent Antivenom Product Description
11.2.5 Merck Recent Developments
11.3 BTG
11.3.1 BTG Corporation Information
11.3.2 BTG Overview
11.3.3 BTG Monovalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 BTG Monovalent Antivenom Product Description
11.3.5 BTG Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Monovalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Pfizer Monovalent Antivenom Product Description
11.4.5 Pfizer Recent Developments
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Haffkine Bio-Pharmaceutical Corporation Information
11.5.2 Haffkine Bio-Pharmaceutical Overview
11.5.3 Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Haffkine Bio-Pharmaceutical Monovalent Antivenom Product Description
11.5.5 Haffkine Bio-Pharmaceutical Recent Developments
11.6 Vins Bioproducts
11.6.1 Vins Bioproducts Corporation Information
11.6.2 Vins Bioproducts Overview
11.6.3 Vins Bioproducts Monovalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Vins Bioproducts Monovalent Antivenom Product Description
11.6.5 Vins Bioproducts Recent Developments
11.7 Serum Biotech
11.7.1 Serum Biotech Corporation Information
11.7.2 Serum Biotech Overview
11.7.3 Serum Biotech Monovalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Serum Biotech Monovalent Antivenom Product Description
11.7.5 Serum Biotech Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Monovalent Antivenom Value Chain Analysis
12.2 Monovalent Antivenom Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Monovalent Antivenom Production Mode & Process
12.4 Monovalent Antivenom Sales and Marketing
12.4.1 Monovalent Antivenom Sales Channels
12.4.2 Monovalent Antivenom Distributors
12.5 Monovalent Antivenom Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Monovalent Antivenom Industry Trends
13.2 Monovalent Antivenom Market Drivers
13.3 Monovalent Antivenom Market Challenges
13.4 Monovalent Antivenom Market Restraints

14 Key Findings in The Global Monovalent Antivenom Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Monovalent Antivenom Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Coral Snakes Antivenom
Table 3. Major Manufacturers of Sea Snakes Antivenom
Table 4. Major Manufacturers of Brown Snake Antivenom
Table 5. Major Manufacturers of Others
Table 6. Global Monovalent Antivenom Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Monovalent Antivenom Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Monovalent Antivenom Sales by Region (2016-2021) & (K Units)
Table 9. Global Monovalent Antivenom Sales Market Share by Region (2016-2021)
Table 10. Global Monovalent Antivenom Sales by Region (2022-2027) & (K Units)
Table 11. Global Monovalent Antivenom Sales Market Share by Region (2022-2027)
Table 12. Global Monovalent Antivenom Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Monovalent Antivenom Revenue Market Share by Region (2016-2021)
Table 14. Global Monovalent Antivenom Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Monovalent Antivenom Revenue Market Share by Region (2022-2027)
Table 16. Global Monovalent Antivenom Sales by Manufacturers (2016-2021) & (K Units)
Table 17. Global Monovalent Antivenom Sales Share by Manufacturers (2016-2021)
Table 18. Global Monovalent Antivenom Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Monovalent Antivenom Revenue Share by Manufacturers (2016-2021)
Table 20. Monovalent Antivenom Price by Manufacturers 2016-2021 (US$/Unit)
Table 21. Global Monovalent Antivenom Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Monovalent Antivenom by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monovalent Antivenom as of 2020)
Table 23. Monovalent Antivenom Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Monovalent Antivenom Product Offered
Table 25. Date of Manufacturers Enter into Monovalent Antivenom Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Monovalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 28. Global Monovalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 29. Global Monovalent Antivenom Sales Share by Type (2016-2021)
Table 30. Global Monovalent Antivenom Sales Share by Type (2022-2027)
Table 31. Global Monovalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Monovalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Monovalent Antivenom Revenue Share by Type (2016-2021)
Table 34. Global Monovalent Antivenom Revenue Share by Type (2022-2027)
Table 35. Monovalent Antivenom Price by Type (2016-2021) & (US$/Unit)
Table 36. Global Monovalent Antivenom Price Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Monovalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 38. Global Monovalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 39. Global Monovalent Antivenom Sales Share by Application (2016-2021)
Table 40. Global Monovalent Antivenom Sales Share by Application (2022-2027)
Table 41. Global Monovalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Monovalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Monovalent Antivenom Revenue Share by Application (2016-2021)
Table 44. Global Monovalent Antivenom Revenue Share by Application (2022-2027)
Table 45. Monovalent Antivenom Price by Application (2016-2021) & (US$/Unit)
Table 46. Global Monovalent Antivenom Price Forecast by Application (2022-2027) & (US$/Unit)
Table 47. North America Monovalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 48. North America Monovalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 49. North America Monovalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Monovalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Monovalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 52. North America Monovalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 53. North America Monovalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Monovalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Monovalent Antivenom Sales by Country (2016-2021) & (K Units)
Table 56. North America Monovalent Antivenom Sales by Country (2022-2027) & (K Units)
Table 57. North America Monovalent Antivenom Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Monovalent Antivenom Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Monovalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 60. Europe Monovalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 61. Europe Monovalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Monovalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Monovalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 64. Europe Monovalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 65. Europe Monovalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Monovalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Monovalent Antivenom Sales by Country (2016-2021) & (K Units)
Table 68. Europe Monovalent Antivenom Sales by Country (2022-2027) & (K Units)
Table 69. Europe Monovalent Antivenom Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Monovalent Antivenom Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Monovalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 72. Asia Pacific Monovalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 73. Asia Pacific Monovalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Monovalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Monovalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 76. Asia Pacific Monovalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 77. Asia Pacific Monovalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Monovalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Monovalent Antivenom Sales by Region (2016-2021) & (K Units)
Table 80. Asia Pacific Monovalent Antivenom Sales by Region (2022-2027) & (K Units)
Table 81. Asia Pacific Monovalent Antivenom Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Monovalent Antivenom Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Monovalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 84. Latin America Monovalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 85. Latin America Monovalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Monovalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Monovalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 88. Latin America Monovalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 89. Latin America Monovalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Monovalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Monovalent Antivenom Sales by Country (2016-2021) & (K Units)
Table 92. Latin America Monovalent Antivenom Sales by Country (2022-2027) & (K Units)
Table 93. Latin America Monovalent Antivenom Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Monovalent Antivenom Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Monovalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 96. Middle East and Africa Monovalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 97. Middle East and Africa Monovalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Monovalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Monovalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 100. Middle East and Africa Monovalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 101. Middle East and Africa Monovalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Monovalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Monovalent Antivenom Sales by Country (2016-2021) & (K Units)
Table 104. Middle East and Africa Monovalent Antivenom Sales by Country (2022-2027) & (K Units)
Table 105. Middle East and Africa Monovalent Antivenom Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Monovalent Antivenom Revenue by Country (2022-2027) & (US$ Million)
Table 107. CSL Corporation Information
Table 108. CSL Description and Major Businesses
Table 109. CSL Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. CSL Monovalent Antivenom Product
Table 111. CSL Recent Developments
Table 112. Merck Corporation Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Merck Monovalent Antivenom Product
Table 116. Merck Recent Developments
Table 117. BTG Corporation Information
Table 118. BTG Description and Major Businesses
Table 119. BTG Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. BTG Monovalent Antivenom Product
Table 121. BTG Recent Developments
Table 122. Pfizer Corporation Information
Table 123. Pfizer Description and Major Businesses
Table 124. Pfizer Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. Pfizer Monovalent Antivenom Product
Table 126. Pfizer Recent Developments
Table 127. Haffkine Bio-Pharmaceutical Corporation Information
Table 128. Haffkine Bio-Pharmaceutical Description and Major Businesses
Table 129. Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. Haffkine Bio-Pharmaceutical Monovalent Antivenom Product
Table 131. Haffkine Bio-Pharmaceutical Recent Developments
Table 132. Vins Bioproducts Corporation Information
Table 133. Vins Bioproducts Description and Major Businesses
Table 134. Vins Bioproducts Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Vins Bioproducts Monovalent Antivenom Product
Table 136. Vins Bioproducts Recent Developments
Table 137. Serum Biotech Corporation Information
Table 138. Serum Biotech Description and Major Businesses
Table 139. Serum Biotech Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Serum Biotech Monovalent Antivenom Product
Table 141. Serum Biotech Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Monovalent Antivenom Distributors List
Table 145. Monovalent Antivenom Customers List
Table 146. Monovalent Antivenom Market Trends
Table 147. Monovalent Antivenom Market Drivers
Table 148. Monovalent Antivenom Market Challenges
Table 149. Monovalent Antivenom Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Monovalent Antivenom Product Picture
Figure 2. Global Monovalent Antivenom Market Share by Type in 2020 & 2027
Figure 3. Coral Snakes Antivenom Product Picture
Figure 4. Sea Snakes Antivenom Product Picture
Figure 5. Brown Snake Antivenom Product Picture
Figure 6. Others Product Picture
Figure 7. Global Monovalent Antivenom Market Share by Application in 2020 & 2027
Figure 8. Non-profit Institutions
Figure 9. Hospitals and Clinic
Figure 10. Monovalent Antivenom Report Years Considered
Figure 11. Global Monovalent Antivenom Sales 2016-2027 (K Units)
Figure 12. Global Monovalent Antivenom Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Monovalent Antivenom Revenue 2016-2027 (US$ Million)
Figure 14. Global Monovalent Antivenom Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Monovalent Antivenom Sales Market Share by Region (2016-2021)
Figure 16. Global Monovalent Antivenom Sales Market Share by Region (2022-2027)
Figure 17. North America Monovalent Antivenom Sales YoY (2016-2027) & (K Units)
Figure 18. North America Monovalent Antivenom Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Monovalent Antivenom Sales YoY (2016-2027) & (K Units)
Figure 20. Europe Monovalent Antivenom Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Monovalent Antivenom Sales YoY (2016-2027) & (K Units)
Figure 22. Asia-Pacific Monovalent Antivenom Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Monovalent Antivenom Sales YoY (2016-2027) & (K Units)
Figure 24. Latin America Monovalent Antivenom Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Monovalent Antivenom Sales YoY (2016-2027) & (K Units)
Figure 26. Middle East & Africa Monovalent Antivenom Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Monovalent Antivenom Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Monovalent Antivenom Revenue in 2020
Figure 29. Monovalent Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Monovalent Antivenom Sales Market Share by Type (2016-2027)
Figure 31. Global Monovalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 32. Global Monovalent Antivenom Sales Market Share by Application (2016-2027)
Figure 33. Global Monovalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 34. North America Monovalent Antivenom Sales Market Share by Type (2016-2027)
Figure 35. North America Monovalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 36. North America Monovalent Antivenom Sales Market Share by Application (2016-2027)
Figure 37. North America Monovalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 38. North America Monovalent Antivenom Sales Share by Country (2016-2027)
Figure 39. North America Monovalent Antivenom Revenue Share by Country (2016-2027)
Figure 40. United States Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Monovalent Antivenom Sales Market Share by Type (2016-2027)
Figure 43. Europe Monovalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 44. Europe Monovalent Antivenom Sales Market Share by Application (2016-2027)
Figure 45. Europe Monovalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 46. Europe Monovalent Antivenom Sales Share by Country (2016-2027)
Figure 47. Europe Monovalent Antivenom Revenue Share by Country (2016-2027)
Figure 48. Germany Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 49. France Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Monovalent Antivenom Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Monovalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Monovalent Antivenom Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Monovalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Monovalent Antivenom Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Monovalent Antivenom Revenue Share by Region (2016-2027)
Figure 59. China Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 62. India Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 64. Taiwan Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Monovalent Antivenom Sales Market Share by Type (2016-2027)
Figure 69. Latin America Monovalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Monovalent Antivenom Sales Market Share by Application (2016-2027)
Figure 71. Latin America Monovalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Monovalent Antivenom Sales Share by Country (2016-2027)
Figure 73. Latin America Monovalent Antivenom Revenue Share by Country (2016-2027)
Figure 74. Mexico Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Monovalent Antivenom Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Monovalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Monovalent Antivenom Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Monovalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Monovalent Antivenom Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Monovalent Antivenom Revenue Share by Country (2016-2027)
Figure 83. Turkey Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Monovalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 86. Monovalent Antivenom Value Chain
Figure 87. Monovalent Antivenom Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---